Health Care & Life Sciences » Pharmaceuticals | Torii Pharmaceutical Co. Ltd.

Torii Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values JPY Millions.
2014
2015
2016
2017
2018
Sales/Revenue
58,109
62,378
60,206
64,135
62,551
Cost of Goods Sold (COGS) incl. D&A
26,588
31,207
30,707
31,720
32,194
Gross Income
31,521
31,171
29,499
32,415
30,357
SG&A Expense
26,534
26,252
25,679
26,132
25,405
EBIT
4,987
4,919
3,820
6,283
4,952
Unusual Expense
-
142
-
-
2,043
Non Operating Income/Expense
57
398
196
64
71
Interest Expense
-
-
-
1
-
Pretax Income
5,133
5,258
4,056
6,373
3,030
Income Tax
1,781
1,731
1,216
1,655
1,865
Consolidated Net Income
3,352
3,527
2,839
4,718
1,164
Net Income
3,352
3,527
2,839
4,718
1,164
Net Income After Extraordinaries
3,352
3,527
2,839
4,718
1,164
Net Income Available to Common
3,352
3,527
2,839
4,718
1,164
EPS (Basic)
118.45
124.63
100.38
168.21
41.49
Basic Shares Outstanding
28
28
28
28
28
EPS (Diluted)
118.45
124.63
100.38
168.21
41.49
Diluted Shares Outstanding
28
28
28
28
28
EBITDA
6,921
7,200
6,177
8,518
6,957
Non-Operating Interest Income
89
83
39
27
53

About Torii Pharmaceutical Co.

View Profile
Address
Torii Nihonbashi Building
Tokyo Tokyo 103
Japan
Employees -
Website http://www.torii.co.jp
Updated 07/08/2019
Torii Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products are mainly used in the areas of renal diseases and hemodialysis, human immunodeficiency virus (HIV), skin diseases and allergies, active bacteria formulation (laxative), tocolysis, eclampsia and others. The company was founded by Tokubei Torii in 1872 and is headquartered in Tokyo, Japan.